Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Related Keywords
Mayank Tandon , Eric Sheridan , Absci Corporation , James Quigley , T Inc , Lithium Americas Corp , Volato Group Inc , Ally Financial Inc , Robot Corporation , Bullfrog Ai Holdings Inc , Goldman Sachs , Vision Marine Technologies Inc , Mesoblast Limited , Portage Biotech Inc , United Airlines , Datasea Inc , Celsius Holdings Inc , Adagene Inc , Processa Pharmaceuticals , Vodafone , Promis Neurosciences Inc , Tricon Residential Inc , Wheels Up Experience Inc , Hertz Global Holdings Inc , Chegg Inc , Cyngn Inc , Wayfair Inc , Transcode Therapeutics Inc , Mesa Air Group Inc , Holdings Limited , Newamsterdam Pharma Company , Nasdaq , Blackstone Real Estate Income Trust Inc , Esperion Therapeutics Inc , Edgewise Therapeutics Inc , Spirit Airlines Inc , Azitra Inc , Enterprises Inc , Processa Pharmaceuticals Inc , Orgenesis Inc , Super Micro Computer Inc , Gaming Entertainment Inc , Treasure Global Inc , Morgan Stanley , Shuttle Pharmaceuticals Holdings Inc , Kaman Corporation , Nkarta Inc , Biocardia Inc , Diagnostics Inc , Agrify Corporation , Jetblue , Spacemobile Inc , Transcode Therapeutics , Code Therapeutics , Tricon Residential , Blackstone Real Estate Income Trust , Micro Computer , Pharmaceuticals Holdings , Road Medical , Ally Financial , Rare Pediatric Disease Designation , Golden Lake Business , Marine Technologies , Global Holdings ,
comparemela.com © 2020. All Rights Reserved.